Hepatitis B virus reactivation in patients undergoing immune checkpoint inhibition: systematic review with meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Hepatitis B virus reactivation in patients undergoing immune checkpoint inhibition: systematic review with meta-analysis

Published:2022-06-29 Issue:5 Volume:149 Page:1993-2008
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Ding Zi-Niu,Meng Guang-Xiao,Xue Jun-Shuai,Yan Lun-Jie,Liu Hui,Yan Yu-Chuan,Chen Zhi-Qiang,Hong Jian-Guo,Wang Dong-Xu,Dong Zhao-Ru,Li Tao

Funder

National Natural Science Foundation of China

Major basic research of Shandong Provincial Natural Science Foundation

Funds for Independent Cultivation of Innovative Team from Universities in Jinan

Taishan Scholars Program for Young Expert of Shandong Province

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00432-022-04133-8.pdf

Reference60 articles.

1. Barber DL, Wherry EJ, Masopust D, Zhu B, Allison JP, Sharpe AH et al (2006) Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439(7077):682–687. https://doi.org/10.1038/nature04444

2. Byeon S, Cho JH, Jung HA, Sun JM, Lee SH, Ahn JS et al (2020) PD-1 inhibitors for non-small cell lung cancer patients with special issues: real-world evidence. Cancer Med 9(7):2352–2362. https://doi.org/10.1002/cam4.2868

3. Chan GH, Gwee YX, Low JL, Huang Y, Chan ZY, Choo JR et al (2020) Immune checkpoint inhibition for non-small cell lung cancer in patients with pulmonary tuberculosis or Hepatitis B: experience from a single Asian centre. Lung Cancer 146:145–153. https://doi.org/10.1016/j.lungcan.2020.05.020

4. Choi J, Lim YS (2017) Characteristics, prevention, and management of hepatitis B virus (HBV) reactivation in HBV-infected patients who require immunosuppressive therapy. J Infect Dis 216(Suppl_8):S778–S784. https://doi.org/10.1093/infdis/jix178

5. Cohen EEW, Soulières D, Le Tourneau C, Dinis J, Licitr L, Ahn MJ et al (2019) Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study. Lancet 393(10167):156–167. https://doi.org/10.1016/s0140-6736(18)31999-8

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis B Virus Reactivation in Cancer Patients Receiving Chemotherapy—A Systematic Review and Meta-Analysis;Seminars in Oncology;2024-08

2. Hepatobiliary complications of immune checkpoint inhibitors in cancer;Exploration of Targeted Anti-tumor Therapy;2024-07-26

3. Current perspectives of viral hepatitis;World Journal of Gastroenterology;2024-05-14

4. Approach to diagnosis and management of reactivation of chronic hepatitis B;Future Virology;2024-05-02

5. Management of Hepatitis B Virus and Hepatitis C Virus Infections in Patients with Cancer Receiving Immune Checkpoint Inhibitors;Journal of Immunotherapy and Precision Oncology;2024-05-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3